Answers are grounded in this paper and cite their sources.
models incorporating the cellular interactions that take place in the TME. In this review, we describe how advances in immuno-oncology and patient-derived models, such as patient-derived organoids and explant cultures, have enhanced the landscape of personalised immunotherapy prediction and treatment of solid organ malignancies. We describe and compare different immunological targets and perspectives on two-dimensional and three-dimensional modelling approaches that may be used to better rationalise immunotherapy use, ultimately providing a knowledge base for the integration of the autologous TME into these predictive models.
No takes yet. Share an insight, caveat, or question.
Mackenzie et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: